Overview / Abstract: |
Learning Objectives -Understand the evolving landscape of hepatitis C therapy and the preliminary efficacy. This activity was originally presented as part of the American Conference for the Treatment of HIV (ACTHIV) 2013 Annual Conference, which was held March 21-23, 2013 in Denver, CO. |
Expiration |
Aug 01, 2014 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Social Work CE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
0.75 AMA PRA Category 1 Credit(s)™ |
Accreditation |
The enduring material is jointly sponsored/co-provided by William Beaumont Hospital, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV). |
Presenters / Authors / Faculty |
0.75 AMA PRA Category 1 Credit(s)™ |
Activity Specialities / Related Topics |
Infectious Disease, HIV / AIDS, Gastroenterology / GI, Family Medicine |
Sponsors / Supporters / Grant Providers |
The Conference and this web archive were supported by educational grants from Bristol-Myers Squibb; Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co; and ViiV Healthcare. |
Keywords / Search Terms |
American Academy of CME American Academy of CME American Academy of CME HIV, AIDS, Antiretroviral Therapy, ART Free CE CME, American Conference for the Treatment of HIV, ACTHIV, hepatitis, HCV, hepatology, co-infection Free CE CME Free CE CME |